These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 24503567)

  • 1. Assessing pharmacokinetics of different doses of fosfomycin in laboratory rats enables adequate exposure for pharmacodynamic models.
    Poeppl W; Lingscheid T; Bernitzky D; Donath O; Reznicek G; Zeitlinger M; Burgmann H
    Pharmacology; 2014; 93(1-2):65-8. PubMed ID: 24503567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of a single bolus intravenous, intramuscular and subcutaneous dose of disodium fosfomycin in horses.
    Zozaya DH; Gutiérrez OL; Ocampo CL; Sumano LH
    J Vet Pharmacol Ther; 2008 Aug; 31(4):321-7. PubMed ID: 18638292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of disodium-fosfomycin in mongrel dogs.
    Gutierrez OL; Ocampo CL; Aguilera JR; Luna J; Sumano LH
    Res Vet Sci; 2008 Aug; 85(1):156-61. PubMed ID: 17910966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous and intramuscular pharmacokinetics of a single-daily dose of disodium-fosfomycin in cattle, administered for 3 days.
    Sumano LH; Ocampo CL; Gutierrez OL
    J Vet Pharmacol Ther; 2007 Feb; 30(1):49-54. PubMed ID: 17217401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-dose pharmacokinetics of fosfomycin during continuous venovenous haemofiltration.
    Gattringer R; Meyer B; Heinz G; Guttmann C; Zeitlinger M; Joukhadar C; Dittrich P; Thalhammer F
    J Antimicrob Chemother; 2006 Aug; 58(2):367-71. PubMed ID: 16782745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of fosfomycin in chickens after a single intravenous dose and tissue levels following chronic oral administration.
    Aramayona JJ; Bregante MA; Solans C; Rueda S; Fraile LJ; Garcia MA
    Vet Res; 1997; 28(6):581-8. PubMed ID: 9428152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase I Study To Evaluate the Pharmacokinetics, Safety, and Tolerability of Two Dosing Regimens of Oral Fosfomycin Tromethamine in Healthy Adult Participants.
    Wenzler E; Bleasdale SC; Sikka M; Bunnell KL; Finnemeyer M; Rosenkranz SL; Danziger LH; Rodvold KA;
    Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29891606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous fosfomycin for the treatment of multidrug-resistant pathogens: what is the evidence on dosing regimens?
    Dimopoulos G; Koulenti D; Parker SL; Roberts JA; Arvaniti K; Poulakou G
    Expert Rev Anti Infect Ther; 2019 Mar; 17(3):201-210. PubMed ID: 30668931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disodium-fosfomycin pharmacokinetics and bioavailability in post weaning piglets.
    Soraci AL; Perez DS; Martinez G; Dieguez S; Tapia MO; Amanto F; Harkes R; Romano O
    Res Vet Sci; 2011 Jun; 90(3):498-502. PubMed ID: 20696447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The plasma pharmacokinetics of fosfomycin and metronidazole after intraperitoneal administration in patients undergoing appendectomy for uncomplicated appendicitis.
    Fonnes S; Weisser JJ; Holzknecht BJ; Arpi M; Rosenberg J
    Fundam Clin Pharmacol; 2020 Aug; 34(4):504-512. PubMed ID: 31944378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concentrations of fosfomycin in the cerebrospinal fluid of neurointensive care patients with ventriculostomy-associated ventriculitis.
    Pfausler B; Spiss H; Dittrich P; Zeitlinger M; Schmutzhard E; Joukhadar C
    J Antimicrob Chemother; 2004 May; 53(5):848-52. PubMed ID: 15056646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution and antimicrobial activity of fosfomycin in the interstitial fluid of human soft tissues.
    Frossard M; Joukhadar C; Erovic BM; Dittrich P; Mrass PE; Van Houte M; Burgmann H; Georgopoulos A; Müller M
    Antimicrob Agents Chemother; 2000 Oct; 44(10):2728-32. PubMed ID: 10991852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibiotic abscess penetration: fosfomycin levels measured in pus and simulated concentration-time profiles.
    Sauermann R; Karch R; Langenberger H; Kettenbach J; Mayer-Helm B; Petsch M; Wagner C; Sautner T; Gattringer R; Karanikas G; Joukhadar C
    Antimicrob Agents Chemother; 2005 Nov; 49(11):4448-54. PubMed ID: 16251282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is fosfomycin a potential treatment alternative for multidrug-resistant gram-negative prostatitis?
    Gardiner BJ; Mahony AA; Ellis AG; Lawrentschuk N; Bolton DM; Zeglinski PT; Frauman AG; Grayson ML
    Clin Infect Dis; 2014 Feb; 58(4):e101-5. PubMed ID: 24170195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A reappraisal of current dosing strategies for intravenous fosfomycin in children and neonates.
    Traunmüller F; Popovic M; Konz KH; Vavken P; Leithner A; Joukhadar C
    Clin Pharmacokinet; 2011 Aug; 50(8):493-503. PubMed ID: 21740073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimal timing of oral fosfomycin administration for pre-prostate biopsy prophylaxis.
    Rhodes NJ; Gardiner BJ; Neely MN; Grayson ML; Ellis AG; Lawrentschuk N; Frauman AG; Maxwell KM; Zembower TR; Scheetz MH
    J Antimicrob Chemother; 2015 Jul; 70(7):2068-73. PubMed ID: 25802286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exposure variability of fosfomycin administered to pigs in food or water: impact of social rank.
    Soraci AL; Amanto F; Tapia MO; de la Torre E; Toutain PL
    Res Vet Sci; 2014 Feb; 96(1):153-9. PubMed ID: 24388282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High fosfomycin concentrations in bone and peripheral soft tissue in diabetic patients presenting with bacterial foot infection.
    Schintler MV; Traunmüller F; Metzler J; Kreuzwirt G; Spendel S; Mauric O; Popovic M; Scharnagl E; Joukhadar C
    J Antimicrob Chemother; 2009 Sep; 64(3):574-8. PubMed ID: 19578081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High interindividual variability in urinary fosfomycin concentrations in healthy female volunteers.
    Wijma RA; Koch BCP; van Gelder T; Mouton JW
    Clin Microbiol Infect; 2018 May; 24(5):528-532. PubMed ID: 28867662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of the pharmacokinetic and pharmacodynamic characteristics of fosfomycin for the treatment of patients with systemic infections.
    Roussos N; Karageorgopoulos DE; Samonis G; Falagas ME
    Int J Antimicrob Agents; 2009 Dec; 34(6):506-15. PubMed ID: 19828298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.